Clinical trials
Diabetes (Insulin-requiring, Type 1 or Type 2) clinical trials
Below are recruiting diabetes (insulin-requiring, type 1 or type 2) clinical trials, each written for real people, not researchers. We’re tracking 2,182 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07232615Recruiting
Comparing two types of trifocal lenses for cataract surgery
This study compares two different trifocal toric intraocular lenses (special lenses that correct both near, far, and astigmatism) used during cataract surgery. Researchers want to see which lens gives better results for people with cataracts and astigmatism.
Düsseldorf, North Rhine-WestphaliaAges 21 years+ - NCT07243665Recruiting
Glaucoma screening with AI for diabetes patients
This trial tests whether artificial intelligence can help find glaucoma early in people with diabetes who already get regular eye checks for diabetic eye disease. It may help catch glaucoma sooner without extra tests.
Singapore, SingaporeAges 21 years+ - NCT07247084RecruitingPhase 4
Tirzepatide for weight loss in adults with obesity
This trial tests if tirzepatide is more effective than standard obesity treatments for adults who have a BMI between 30 and 35 and one weight-related health condition, but do not have diabetes. The goal is to help you lose weight.
AltrinchamAges 18 years+ - NCT07249905RecruitingPhase 1/Phase 2
Testing MDX2003 for people with relapsed B-cell lymphoma
This trial is testing a new drug, MDX2003, for people with certain types of lymphoma that have come back after at least two prior treatments. It aims to see how safe the drug is and if it can shrink tumors.
Richmond, VictoriaAges 18 years+ - NCT04131413RecruitingPhase 1
HPV vaccine given through the skin for HPV16 cervical disease
This early-phase study tests a vaccine designed to help your immune system fight HPV16, a type of human papillomavirus linked to abnormal cells in the cervix. You may or may not be living with HIV, and the team will check safety and immune response after giving the vaccine in a specific way.
Birmingham, AlabamaAges 19 years+ - NCT07257653RecruitingPhase 2
Cetuximab beta plus fruquintinib with or without immunotherapy for first-line advanced colorectal cancer
This trial tests a combination of two targeted drugs (cetuximab beta and fruquintinib) with or without an immunotherapy drug for people with a specific type of advanced colorectal cancer that has not been treated before. It aims to see if this approach is safe and effective for those whose tumors have certain genetic markers (RAS and BRAF wild type).
Hangzhou, ZhejiangAges 10–85 - NCT07269743Recruiting
Aerosol therapy for ARDS patients on ventilators
This trial tests whether delivering medication through a ventilator mask (aerosol therapy) can help adults with ARDS breathe better. It is designed for patients who are already on a breathing machine.
Lucknow, Uttar PradeshAges 18 years+ - NCT07271771RecruitingPhase 4
Denosumab for muscle and insulin in diabetes
This study tests whether denosumab, a medication that strengthens bones, can also improve muscle strength and insulin sensitivity in postmenopausal women with type 2 diabetes who take metformin.
AarhusAges 40 years+ - NCT07276386RecruitingPhase 2
Combination therapy for metastatic uveal melanoma
This trial tests a two-part treatment for uveal melanoma that has spread to the liver. First, you get a liver-directed chemotherapy (melphalan) through a special procedure called PHP, then you receive an immunotherapy drug (tebentafusp) that helps your immune system attack the cancer.
Tampa, FloridaAges 18 years+ - NCT07286747RecruitingPhase 2
Nicotinic Acid for Reversing Prediabetes
This trial tests whether a controlled-release form of nicotinic acid (a type of vitamin B3) can help people with prediabetes get their blood sugar back to normal. It also looks at how the treatment affects liver health.
KielAges 18–79 - NCT07288034RecruitingPhase 2
Immunotherapy biomarkers for advanced lung cancer
This study looks at blood and tissue biomarkers to predict how well immunotherapy (with or without chemotherapy) works for advanced non-small cell lung cancer. It also helps decide the best second treatment if the first one stops working.
Goodyear, ArizonaAges 18 years+ - NCT07302854RecruitingPhase 2/Phase 3
Clot-busting medicine for medium vessel strokes
This trial tests a new clot-busting medicine called tenecteplase, given directly into the blood vessel in the brain, to treat strokes caused by a blockage in a medium-sized artery. The goal is to see if it can help restore blood flow and reduce disability, especially for patients who can be treated within 24 hours of stroke onset.
Wuhan, HubeiAges 18 years+ - NCT07304817RecruitingPhase 2
Comparing two heart and kidney medicines in heart failure
This study tests if a new medicine (vicadrostat) works differently than an older one (spironolactone) in people with heart failure or heart disease and reduced kidney function. It aims to understand how they affect proteins in the blood and kidney blood flow.
Groningen, Provincie GroningenAges 18 years+ - NCT07327684Recruiting
Imaging brown fat activity with ultrasound
This study uses a special camera (photoacoustic/ultrasound) to look at a type of fat called 'brown fat' that helps your body burn energy. You may be able to join as a healthy volunteer or if you have a condition like type 2 diabetes or PCOS.
BeijingAges 18–80 - NCT07331506Recruiting
Early detection of breast cancer with a blood test
This trial tests a new blood test called Oncoliq to see if it can find breast cancer early. It compares results from people with breast cancer and people without cancer.
Buenos Aires, Buenos AiresAges 40–70 - NCT07339423RecruitingPhase 3
A study of a new medicine for weight loss
This study tests a new medicine to see how well it helps people with excess body weight lose weight. It may be an option if you have tried to lose weight through dieting before but haven't had lasting success.
Miramar, FloridaAges 18 years+ - NCT07346079RecruitingPhase 4
Corticotropin gel for acute gout flares
This study tests two doses of a medicine called Purified Cortrophin Gel for people having a gout flare that started in the last 5 days. It might be an option if other treatments haven't worked or aren't safe for you.
Boston, MassachusettsAges 18–90 - NCT07347171RecruitingPhase 1
Testing CG009301 for blood cancers that returned or didn't respond
This trial tests a new drug called CG009301 for people with blood cancers that have come back or haven't responded to standard treatments. The goal is to see if the drug is safe and works against these cancers.
NanchangAges 18–75 - NCT07348692RecruitingPhase 3
Pneumonia vaccine study for healthy infants 2 months old
This study tests a new vaccine that protects against 21 types of bacteria that cause pneumonia and other infections. It is for healthy infants around 2 months old to see if it works as well as the current vaccine.
Fayetteville, ArkansasAges 1 month–3 months - NCT07376200RecruitingPhase 1
First-in-human study of a new injection (HEC-151)
This study tests a new injection called HEC-151 in healthy men to see how it affects the body at different single doses. It's one of the first steps to see if the drug is safe and could one day help people with diabetes or related conditions.
Chongqing, BishanAges 18–45 - NCT07376707RecruitingPhase 1
Study of TGI-5 alone or with nivolumab for advanced solid tumors
This trial tests a new drug called TGI-5, either by itself or combined with another drug (nivolumab), for people with advanced cancer that hasn't responded to standard treatments. It's looking for patients with certain types of solid tumors, especially colorectal, melanoma, lung, or others that have stopped responding to therapy.
ShanghaiAges 18 years+ - NCT07382817RecruitingPhase 1
A study of CAR T cells for patients with certain T or NK cell cancers
This trial tests whether a new treatment, called CAR T cells that target CD94, can help people with specific types of T or NK cell lymphoma or leukemia that have not responded to other treatments or have come back. The goal is to see if it is safe and works against the cancer.
Houston, TexasAges 18 years+ - NCT07387445Recruiting
Time-Restricted Eating During Breast Cancer Chemotherapy
This trial tests whether eating only during certain hours of the day (time-restricted eating) is doable and helpful for people receiving chemotherapy for breast cancer. The goal is to see if this eating pattern can be a safe way to support your health during treatment.
Chicago, IllinoisAges 25–99 - NCT07391319RecruitingPhase 3
Testing a new treatment for diabetic foot ulcers
This trial tests a new treatment for foot ulcers caused by poor blood flow and diabetes. It compares the new treatment to a placebo (an inactive substance) to see if it helps ulcers heal better.
MoscowAges 18 years+
Hear when a new Diabetes (Insulin-requiring, Type 1 or Type 2) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for diabetes (insulin-requiring, type 1 or type 2)?
- Yes. Clin2 currently lists 2,182 recruiting diabetes (insulin-requiring, type 1 or type 2) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a diabetes (insulin-requiring, type 1 or type 2) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a diabetes (insulin-requiring, type 1 or type 2) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.